# CoStim Pharmaceuticals Inc. — Form D

CoStim Pharmaceuticals Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-10. The offering totals $22.3M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-04-10
- Form: D
- Accession: 0001573655-13-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $22.3M
- Amount sold: $10.0M
- Remaining: $12.3M
- Investors: 5
- Date of first sale: 2013-03-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-194766

## Issuer

- Name: CoStim Pharmaceuticals Inc.
- CIK: 0001573655
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 200 CLARENDON STREET, BOSTON, MA, 02116
- Phone: 617-945-0079

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Luke Evnin | Director | Watertown, MA |
| Jean-Francois Formela | Director | Cambridge, MA |
| Roger Kitterman | Director | Boston, MA |
| Robert Millman | Director | MEDFIELD, MA |
| Marian Nakada | Director | Ann Arbor, MI |
| Josh Resnick | Director | Walthum, MA |
| Kazumi Shiosaki | Director | Watertown, MA |
| Robert Millman | Executive Officer | MEDFIELD, MA |

## More

- [CIK 1573655 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1573655&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001573655-13-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.